Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Org chart
Michael McElhaugh
Collapse
David C. Hastings
Chief Financial Officer
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Michael J. Sofia Phd
Chief Scientific Officer
Karen Sims
Chief Medical Officer
Catherine Coffey Ross
Vice President Commercial Development
Michael Child
Vice President Clinical Operations
Shannon Briscoe
Vice President Human Resources
Ganapati Reddy Pamulapati
Senior Vice President, Pharmaceutical Development And Manufacturing
Similar companies
REVOLUTION Medicines
5 followers
Halozyme Therapeutics
4 followers
Stemline Therapeutics
3 followers
Celularity
3 followers
Atomwise
3 followers
Pivot Bio
2 followers
Quantum-Si
2 followers
Keros Therapeutics
1 follower
Vividion Therapeutics
1 follower
Century Therapeutics
1 follower
Passage Bio
1 follower
Discover companies